D endritic cells (DCs)
3 are a type of APCs that are present in virtually all tissues. They are crucial for initiation and regulation of immune responses against pathogens and are important for maintaining steady-state self-tolerance. The maturation of DCs is initiated through pattern recognition receptors, such as TLRs (1), upon Ag conjugation. By capturing, processing, and presenting Ags, DCs move into local draining lymph nodes as they mature, resulting in the initiation of T cell activation and adaptive immune responses (2) .
In mouse spleen and lymph nodes, DCs are heterogeneously distributed but they are generally subdivided into two major groups: conventional DCs (cDCs) and plasmacytoid DCs (3) . cDCs can be further divided into CD4 ϩ CD8 Ϫ , CD4 Ϫ CD8 Ϫ , and CD4 Ϫ CD8 ϩ subsets (4, 5) . The developmental pathways that regulate differentiation of DCs from hematopoietic stem cells were recently deciphered. In mouse bone marrow, cDCs and plasmacytoid DCs are derived from a common proliferative DC-restricted progenitor that expresses surface fms-like tyrosine kinase-3 (Flt3) and M-CSF receptor (M-CSFR) (6 -8) . A significant number of steady-state cDCs in the spleen are generated from immediate splenic cDC precursors (pre-cDCs), which may be derived from bone marrow DC progenitors through blood circulation (9) . The expression of surface CD24 on splenic pre-cDCs segregates the developmental lineages of CD8 Ϫ and CD8 ϩ DCs (3, 9) . Many transcription factors and cytokines have been implicated in regulation of cDC development. For example, CD8
Ϫ cDC generation is defective in mice lacking IFN-regulatory factor (IRF)-2 (10) and IRF-4 (11) , and the number of CD8 ϩ cDCs is reduced in mice lacking IRF-8 (12) . Flt3 ligand (13) and STAT3 (14) are critical for multiple subsets of DC development. Thus, accumulating evidence suggests there is an important interplay between these positive regulators in the general development of cDCs or development of specific DC subsets.
B lymphocyte-induced maturation protein-1 (Blimp-1), also called PRDI-BF1, was discovered as a transcriptional repressor of the IFN␤ promoter (15) . Blimp-1 orchestrates plasma cell differentiation by regulating cascades of gene expression (16 -18) , controls T cell homeostasis and tolerance (19, 20) , and triggers myeloid lineage differentiation (21) . Blimp-1 expression can be activated in mature B cells in many ways, including activation by TLR ligands (22) (23) (24) . We wonder whether Blimp-1 is involved in DC function as DC maturation is often mediated by TLR activation. Thus, an animal system in which the Blimp-1 gene, Prdm1, was conditionally deleted in the panhematopoietic lineage was generated. In addition to its known roles in B and T cell lineages, we found that Blimp-1 negatively regulates homeostatic development of the CD8 Ϫ cDC subset by maintaining the numbers of immediate cDC precursors that acquire a CD8
Ϫ cDC fate in spleen. We also found that Blimp-1 is critical for DC maturation in response to several stimuli. Together, we have identified two novel roles for Blimp-1 in DC: homeostatic development and maturation in peripheral lymphoid tissues.
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Materials and Methods

Mice and cell lines
Prdm1
f/f mice, generated as described (18) , were bred with Tie2-Cre mice, B6, Tg(Tek-cre)12Flv/J (The Jackson Laboratory). Sex-matched Prdm1 f/f Tie2-Cre ϩ (conditional knockout, CKO) and littermate control (Ctrl) mice (2-to 4-mo-old) were used for all experiments in this study. All mice were maintained under specific pathogen free conditions in the animal facility of the Institute of Cellular and Organismic Biology at Academia Sinica. The Institute Animal Care and Utilization Committee of Academia Sinica approved all experiments. Mice were genotyped by genomic PCR using primers described in supplemental Table I. 4 C57BL/6 and BALB/c mice were purchased from the Laboratory Animal Center in Taiwan and used at 6ϳ10 wk of age. For BrdU labeling in vivo, 1 g BrdU (BD Biosciences) was injected into Ctrl or CKO mice by i.p. at 1 day before sacrifice for flow cytometric analysis of the percentage of BrdU-positive cells in splenic cDC subsets. JAWS II cells purchased from American Type Culture Collection were grown in MEM␣ medium (Invitrogen) supplemented with 20% FBS (Invitrogen), 100 U/ml penicillin, and 100 g/ml streptomycin, 4 mM Lglutamine, 1 mM sodium pyruvate, and 5 ng/ml murine GM-CSF (eBioscience).
Preparation and culture of cells from lymphoid organs
For analysis of cell populations, lymphoid organs were treated with 0.02 mg/ml Liberase Blendzyme II (Roche Applied Science) for 20 min at room temperature. Single cell suspensions were washed with RPMI 1640 (Invitrogen) containing 50 g/ml DNase I (Roche Applied Science) and 3% FCS (HyClone). RBCs were removed using RBC lysis buffer (SigmaAldrich). Splenic CD11c ϩ cells were isolated by positive selection using an autoMACS separator (Miltenyi Biotec) and stimulated with 1 g/ml LPS (from Escherichia coli O26:B6, Sigma-Aldrich) or 100 g/ml poly I:C (Amersham Biosciences) for 1 day in some experiments. Splenic B cells were cultured as described (22) and were stimulated with 2 g/ml LPS for indicated days. Splenic CD4 ϩ T cells were isolated by flow cytometry from total splenocytes cultured with 5 g/ml anti-CD3 (eBioscience) and 10 ng/ml IL-2 (R&D Systems) for 3 days. The immediate splenic DC precursors (pre-cDCs) were defined as previously described (9) . In brief, splenocytes were separated by density using Nycodenz (Axis-Shield), and cells of density between 1.076 and 1.084 were collected. B, T, and NK cells were excluded by staining with specific Abs to CD3, CD19, and CD49b. The lymphocyte-excluded medium-density fraction was further analyzed by the following parameters: low side scatter and expression of CD11c, CD45RA, CD43, SIRP-␣, and CD24.
Bone marrow-derived DC (BMDC) cultures
GM-CSF culture of BMDCs was performed essentially as described (25) . Cells (2 ϫ 10 5 cells/ml) were cultured in RPMI 1640 supplemented with 20 ng/ml murine GM-CSF (eBioscience), 10% FBS (BenchMark), 50 M 2-ME, 100 U/ml penicillin, and 100 g/ml streptomycin. After 8 days in culture, nonadherent cells were harvested as immature BMDCs. The remaining cells were replated at a density of 1 ϫ 10 6 cells/ml for stimulation with 10 ng/ml (or other indicated doses) LPS, 0.5 g/ml poly I:C, 50 ng/ml CpG oligodeoxynucleotides 1826 (InvivoGen), or 10 ng/ml TNF-␣ (PeproTech) for 20 h. In some experiments, immature BMDCs harvested on day 8 were treated for 1 h with the NF-B inhibitor BAY 11-0782 (Calbiochem), or the p38 MAPK inhibitor SB203580 (Calbiochem), followed by LPS stimulation for 20 h. Flt3L-cultured BMDCs were prepared as described (26) . Cells were seeded at 1 ϫ 10 6 cells/ml and cultured in RPMI 1640, supplemented with 50 ng/ml murine Flt3L (R & D Systems), 10% FBS (BenchMark), 50 M 2-ME, 100 U/ml penicillin, and 100 g/ml streptomycin. Cells were left untreated or stimulated with 0.5 g/ml poly I:C or 0.3 M CpG D19 (GGTGCATCGATGCAGGGGGG phosphorothioate-modified at sites underlined) on day 8 and harvested on day 9.
Abs and flow cytometry
Single cell suspensions were stained with appropriate Abs as described in supplemental Table II . For intracellular cytokine staining, T cells were washed and stimulated with 50 ng/ml PMA and 1 g/ml ionomycin (Sigma-Aldrich) in the presence of brefeldin A (Biolegend) for 6 h. After fixation and permeabilization, cells were stained with anti-IFN-␥-APC (Biolegend) and anti-IL-4-PE (Biolegend 
Western blotting and immunofluorescence staining
Western blotting with an anti-Blimp-1 mAb was performed as described (27) . For detection of cytoplasmic IB␣ degradation by rabbit anti-IB␣ Ab (Santa Cruz Biotechnology) or nuclear translocation of p50 subunit by rabbit anti-p50 Ab (Santa Cruz Biotechnology), cytoplasmic and nuclear extracts were prepared as described (22) . Goat anti-lamin B Ab was purchased from Santa Cruz Biotechnology. For NF-B p65 subunit immunofluorescence staining, in brief, BMDCs were left unstimulated or stimulated with 100 ng/ml LPS for 2 h and prepared by cytospin at 500 rpm for 5 min. The cells were then fixed by 4% paraformaldehyde, permeabilized with 0.1% triton X-100, and blocked with 1% BSA, followed by staining with rabbit anti-p65 Ab (Santa Cruz Biotechnology) and Alexa Fluor 555-conjugated goat anti-rabbit IgG (Molecular Probes). The nuclei were counterstained by 4Ј-6-diamidino-2-phenylindole (Sigma-Aldrich). The fluorescent images were examined under a fluorescence microscope (Leica DM6000B). 
Mixed lymphocyte reaction
In vivo DC maturation
Ctrl and CKO mice were subjected to i.p. injection of LPS (3 g/g body weight) solubilized in PBS. Control groups were injected with PBS alone. Ten hours after injection, mice were sacrificed. Single cell suspensions were prepared from mesenteric lymph nodes, stained, and subjected to flow cytometric analysis.
Lentiviral vector preparation and transduction
pFUGW, pFUW-GFPBlimp1, pFUGWCtrli, and pFUGWBlimp1-3952i have been described (27, 28) . Generation of pseudotyped lentivirus was performed essentially as described (27, 29) . Targeted BMDCs and JAWS II cells were infected at a multiplicity of infection of 5 in the presence of 8 g/ml polybrene (Sigma-Aldrich).
Cytometric bead array (CBA), multiplex bead array assays, and ELISA
The Mouse Inflammation CBA Kit (BD Pharmingen) was used in accordance with the manufacturer's protocol to measure select cytokines and chemokines (IL-6, IL-10, MCP-1, IFN-␥, TNF-␣, and IL-12p70) in supernatants from BMDC cultures stimulated with 1 g/ml LPS. Cytokines and chemokines in sera were determined by the MILLIPLEX Mouse Cytokine/ Chemokine kit (Millipore) according to the manufacturer's protocol and analyzed by Luminex 200. IgM production in culture supernatants was determined by ELISA essentially as described (22) .
RNA isolation and reverse transcription-quantitative PCR (RT-QPCR)
These procedures have been described (22) . The gene specific Taqman primer and probe sets, including Prdm1 (assay ID: Mm 00476128_ml) and L32 (used for normalization, assay ID: Mm 00777741_sH) were purchased from Applied Biosystems. The specific primer sets information was described in supplemental Table I .
Chromatin immunoprecipitation (ChIP) assay
Blimp-1 binding in vivo was detected essentially as reported (28, 30) using rabbit antiserum against Blimp-1 as described (31) . In brief, 2ϳ3 ϫ 10 7 Ctrl or CKO BMDCs stimulated with LPS for 24 h were used per ChIP experiment. The immunoprecipitated DNA was analyzed by real-time PCR with SYBR green method on an ABI prism 7300 system. The primer sequences for ChIP assay were listed in the supplemental Table I .
DNA pull-down assay and EMSA
The DNA pull-down assay was performed essentially as described (32) . In brief, biotinylated wild-type or mutated oligonucleotides coupled with streptavidin-conjugated Dynabeads (Invitrogen) were incubated with 150 g precleared nuclear extract prepared from LPS-stimulated Ctrl and CKO BMDCs. After 1 h incubation at room temperature, the complexes were collected with a magnetic apparatus. Coprecipitated proteins were eluted and fractionated by 8% SDS-PAGE, followed by Western blotting analysis. In the competition assay, a 200-fold excess of unlabeled oligonucleotides was added. EMSA was performed using 2.5 g nuclear extract prepared from 293T cells transfected with Blimp-1 expression vector and the LightShift chemiluminescent EMSA kit (Pierce) as described (22) . For the supershift assay, 1 g of mouse anti-Blimp-1 Ab or control Ab (SigmaAldrich) was added to the described reactions and incubated on ice for 30 min. The oligonucleotides used in this study were described in supplemental Table III .
Luciferase assay
Genomic fragments from ϩ69 to ϩ223 of murine Il-6, located in intron 1, and from Ϫ600 to ϩ64 of murine Ccl2 were amplified by PCR from genomic DNA of primary mouse BMDCs derived from C57BL/6 mice and cloned into SmaI/BglII-digested pGL3 promoter vector (Promega) and KpnI/BglII-digested pGL3 basic vector (Promega), respectively. Detailed primer information for luciferase reporter constructions was described in supplemental Table I . JAWS II cells were cotransfected with 0.2ϳ1 g luciferase reporter construct as mentioned above and various amounts (for Il-6 reporter assays: 50, 150, and 450 ng; for Ccl2 reporter assays: 30, 100 and 300 ng) of Blimp-1 expression vector (pCMV-Blimp1) or control vector (pCMV-5b) using TransIT-TKO reagent (Mirus) (33) . Luciferase activity measurement and fold repression calculation was performed as previously described (30) .
Statistical analysis
Statistical significance was measured using the two-tailed paired Student's t test. Data represent means Ϯ SD or means Ϯ SEM as indicated.
Results
Blimp-1 negatively regulates CD8
Ϫ cDC development Prdm1 f/f mice harboring Prdm1 alleles containing two LoxP sites flanking exons 5 and 8 were generated previously (18) and have been used to demonstrate the role of Blimp-1 in B cell differentiation and T cell homeostasis in vivo (18, 19) . To further understand the role of Blimp-1 in the immune system, such as in DC lineage development and function, we deleted Prdm1 in the hematopoietic system by crossing Prdm1 f/f mice with mice expressing the cre-recombinase (Cre) transgene under the control of the Tie2 regulatory element, Tie2-Cre (34) . A three primer-based PCR assay using genomic DNA from various tissues isolated from either CKO mice (Prdm1 f/f Tie2-Cre ϩ ) or littermate control (Ctrl) mice (Prdm1 f/f Tie2-Cre Ϫ ) demonstrated that the Prdm1 allele was efficiently deleted in CKO lymph nodes, spleen, thymus, and bone marrow (Fig. 1A) . Only a small proportion of Prdm1 was deleted in the brain, which is likely explained by endothelial and hematopoietic cells that are present in the brain. Prdm1 alleles were almost completely deleted in purified CD3 ϩ T cells, B220 ϩ B cells, and CD11c ϩ DCs isolated from CKO spleen (Fig. 1A) . Splenic B cells from Prdm1 f/f CD19-Cre ϩ mice fail to differentiate when stimulated with mitogen-like LPS in vitro (18) . Induction of Blimp-1 protein was largely abolished after LPS stimulation of CKO splenic B cells (Fig. 1B) . As anticipated, induction of the plasma cell surface marker CD138 and IgM production were defective when compared with Ctrl B cells (Fig. 1, C  and D) , consistent with the notion that in vitro plasma cell differentiation is impaired in B cells lacking Blimp-1. The frequency of CD44 high CD62L low effector T cells was increased in CKO spleen, and we isolated increased numbers of stimulated CKO splenic IFN-␥-producing T cells ex vivo (Fig. 1, E and F) , consistent with previous reports (19, 20) .
We next examined the percentages and the total cell counts of various immune cell subsets in secondary lymphpoid organs. Fig.  2A shows that the percentages of splenic CD3 ϩ T cells, B220 ϩ B cells, and F4/80 high macrophages were similar in Ctrl and CKO mice. Surprisingly, greater frequency of CD11c high cells was found in CKO mice (Fig. 2B, left) compared with Ctrl mice. The number of DCs found in CKO mice was even greater when we counted the total CD11c high splenic CDCs (Fig. 2B, middle) . The CD11c high populations in the peripheral lymph nodes of CKO mice were similarly augmented (Fig. 2B, right) . Thus, increased DC populations in CKO mice suggest a role for Blimp-1 in DC development.
Next, we found that the percentage of CD8 Ϫ cDCs was greater in CKO spleen than in Ctrl spleen (Fig. 2C) . Correspondingly, the percentage of CD8 ϩ cDCs was less in CKO spleen. However, owing to the increased number of total cDCs in CKO mice, the total number of CD8 ϩ cDCs in CKO spleen remained similar to that in Ctrl spleen, whereas the total number of CD8
Ϫ cDCs was greatly increased in CKO mice (Fig. 2D) . Among the CD8 Ϫ cDCs, the distribution and total number of CD4 ϩ CD8 Ϫ cDCs were significantly increased in CKO mice compared with Ctrl mice (Fig. 2,  E and F) . Despite a decrease in the relative percentage of CD4 Ϫ CD8 Ϫ cDCs in CKO spleen (Fig. 2E) , the total number of CD4 Ϫ CD8 Ϫ cDCs was increased (Fig. 2F) . Therefore, both the CD4 ϩ and CD4 Ϫ subpopulations of the CD8 Ϫ cDC population were expanded in CKO mice.
The expanded steady-state total CD8 Ϫ cDC population in CKO mice could result from increased numbers of bone marrow DC progenitors, changes in the frequency of immediate splenic precursors of the DC subset, and/or changes in cell proliferation/survival. We examined the distribution of DC precursors (defined as Lin Ϫ c-kit ϩ Flt3 ϩ ) (6) and the more restricted DC progenitor subpopulation (defined as Lin
Ctrl and CKO bone marrow cells (Fig. 3A) . The relative percentage of the Lin Ϫ c-kit
ϩ populations was similar in Ctrl and CKO bone marrow (Fig. 3B) , suggesting that the increase in total DC population in CKO mice may not be a consequence of increased generation of DC progenitors from bone marrow hematopoietic stem cells. We next examined splenic pre-cDCs, which are characterized as CD11c ϩ CD45RA low CD43 int SIRP-␣ int (9) . There was no difference in the frequency of splenic pre-cDCs between Ctrl and CKO mice (Fig. 3C) . The immediate splenic CD8
Ϫ cDC precursors were examined by flow cytometric analysis of CD24 low/int cells from pre-cDCs (9, 35) . The relative percentage of CD24 low/int cells was significantly increased in CKO mice (Fig. 3, C and D) , indicating that more CD8
Ϫ cDC immediate precursors were present in CKO spleen than Ctrl spleen. We also found higher steady-state Blimp-1 mRNA levels in CD8 Ϫ cDCs, including CD4 ϩ CD8 Ϫ and CD4 Ϫ CD8 Ϫ cDCs (Fig. 3E) , consistent with these findings that CD8
Ϫ splenic cDCs were preferentially affected in CKO mice. In fact, CD4 ϩ CD8 Ϫ and CD4 Ϫ CD8 Ϫ cDCs have amounts of steadystate Blimp-1 mRNA comparable to those in CD44 high CD62L low effector CD4 ϩ cells and B220 ϩ B cells (Fig. 3E) . The levels of Blimp-1 mRNA in the induced state were also assessed. Like stimulated splenic CD4
ϩ T cells and B cells, Blimp-1 mRNA levels were induced by LPS in CD11c high splenic cDCs (Fig. 3F ).
Loss of IRF-2, IRF-4, or IRF-8 alters CD8
Ϫ or CD8 ϩ cDC distribution in mice (10 -12). However, IRF-2, IRF-4, and IRF-8 mRNA levels in all splenic cDC subsets were similar in Ctrl and CKO mice (supplemental Fig. 1A ). c-myc, which plays a role in cell proliferation, is a direct target of Blimp-1 in several cell lineages (28, 36) . c-myc mRNA levels in each cell subpopulation were similar in Ctrl and CKO mice (supplemental Fig. 1B) . Further investigation of proliferative CD11c high splenic DC subsets in vivo revealed that Ctrl and CKO mice had similar frequencies of BrdU incorporation within CD8 ϩ or CD8 Ϫ splenic DC subsets (supplemental Fig. 2A ). Annexin V staining revealed similar survival rates for CD8
ϩ and CD8 Ϫ splenic cDC subpopulations freshly isolated Fig. 2B ). Collectively, these results suggest that the increased number of steady-state CD8 Ϫ cDCs in CKO spleen likely results from increased generation of immediate CD8 Ϫ cDC precursors.
Stimulus-induced Blimp-1 expression during DC maturation is mediated by NF-B and p38 MAPK pathways
DCs can be generated by addition of GM-CSF in the bone marrow progenitors in culture (37) . We next measured the expression of Blimp-1 in bone marrow cultures supplemented with GM-CSF and evaluated whether its expression changed following stimulus-induced maturation. The Blimp-1 mRNA levels in sorted CD11c ϩ cells obtained from BMDCs were almost equivalent in cells cultured with GM-CSF for 4 and 8 days (Fig. 4A) , whereas Blimp-1 was greatly induced in BMDCs cultured with LPS for 24 h (Fig.  4A) . Similarly, maturation of GM-CSF-cultured BMDCs by TNF-␣, CpG, or poly I:C induced Blimp-1 mRNA and protein expression (Fig. 4, B and C) . Using pharmacological inhibitors, we examined the signaling pathway(s) required for Blimp-1 induction in BMDCs. Induction of Blimp-1 by LPS was inhibited in a dosedependent manner by the NF-B inhibitor BAY 11-0782, and by the p38 MAPK inhibitor SB203580 (Fig. 4D ), but the JNK inhibitor SP600125, the ERK inhibitor PD98059, and the PI3K inhibitor LY294002 had no effect (data not shown). Thus, during BMDC maturation, Blimp-1 is induced by TLR ligands through the p38 MAPK and NF-B pathways.
Blimp-1 is required during DC maturation
We next examined whether BMDCs cultured with GM-CSF required Blimp-1. We verified impaired Blimp-1 induction by LPS treatment of CKO BMDCs cultured with GM-CSF (Fig. 5A) . The maturation status of DCs, which was analyzed by the expression of a panel of surface markers including CD25, CD40, CD86, and MHCII(I-A/E), did not differ significantly between Ctrl and CKO GM-CSF-cultured BMDCs after 8 days of culture (Fig. 5B) , suggesting that Blimp-1 is not essential for DC development under these conditions. Following stimulation with a variety of TLR ligands or by TNF-␣ for 24 h, induction of CD25, CD40, CD86, and MHCII was partially impaired in CKO GM-CSF-cultured BMDCs (Fig. 5B) . Likewise, up-regulation of CD86 and MHCII in BMDCs cultured with GM-CSF derived from C57BL/6 mice was blocked by lentiviral vectors expressing short hairpin RNAs against Blimp-1 (Fig. 5C ), suggesting that impaired maturation of CKO BMDCs is a specific effect. We excluded the possibility that defective BMDC maturation in CKO mice was caused by changes in the levels of various TLR mRNAs (supplemental Fig. 3A) , the kinetics of IB␣ degradation, or nuclear translocation of the NF-B subunits p50 and p65 that is mediated by TLR4 receptor signaling (supplemental Fig. 3, B and C) .
Using a MLR assay, we demonstrated that LPS, poly I:C, CpG, and TNF-␣ stimulation of BMDCs from CKO mice resulted in a partially reduced ability to induce allogeneic T cell proliferation, when compared with Ctrl BMDCs (Fig. 5D) . The significance of Blimp-1 in DC maturation was further strengthened by in vivo experiments. Ten hours after LPS injection of Ctrl mice, CD40, CD54 and CD86 were up-regulated in mesenteric lymph node DCs (Fig. 5E ). By contrast, CKO DCs were resistant to up-regulation of several tested maturation markers following in vivo LPS injection (Fig. 5E) . Interestingly, it has been shown that mesenteric lymph node DCs which generally have higher levels of MHCII are more mature than splenic DCs (38, 39) . This is in agreement with our data that lower basal MHCII levels were found in CKO mesenteric lymph node DCs that are less mature (Fig. 5E ).
Il-6 and Ccl2 were suppressed directly by Blimp-1
We also measured cytokine/chemokine production to assay the function of GM-CSF-cultured BMDCs from Ctrl and CKO mice (Fig. 6A) . After LPS stimulation for 1 day, CKO cultures produced more IL-6 and MCP-1 (encoded by Ccl2) than Ctrl cultures, as determined by CBA (Fig. 6A) , and this increase occurred at the transcription level (supplemental Fig. 4A ). IL-6 and MCP-1 mRNA levels were also increased in LPS-and poly I:C-stimulated splenic CD11c ϩ DCs cultured from CKO mice (supplemental Fig.  4B ). We thus hypothesized that Il-6 and Ccl2 expressed in the DC lineage are subject to Blimp-1 regulation. Il-6 contains three potential Blimp-1 binding sites: one in intron 1 and two in intron 3. The Ccl2 promoter region contains one potential Blimp-1 binding site, as revealed based on known Blimp-1 consensus sites (31) (Fig. 6B) . A ChIP assay using a Blimp-1-specific Ab showed that endogenous Blimp-1 bound to the Il-6 intron 1 and Ccl2 promoter sites in Ctrl BMDCs stimulated with LPS, and that Blimp-1 did not bind significantly to either site in LPS-stimulated CKO BMDCs (Fig. 6C) . In support of this finding, DNA pull-down assay demonstrated that Blimp-1 in nuclear extracts harvested from LPSstimulated Ctrl BMDCs could bind to biotinylated oligonucleotides containing wild-type but not mutated Il-6 or Ccl2 sites (Fig.  6D) , and that competition assays using unlabeled oligonucleotides containing a known Blimp-1 binding site in the c-myc promoter (36) largely reduced the binding (Fig. 6D ). In contrast, nuclear proteins isolated from LPS-stimulated CKO BMDCs bound much less to wild-type Il-6 or Ccl2 biotinylated oligonucleotides (Fig.  6D) . Accordingly, EMSA showed that oligonucleotides containing these sites were shifted by nuclear protein extracts containing exogenously expressed Blimp-1 (supplemental Fig. 5, A and B) . The shifted complex was disrupted by addition of excess unlabeled probe corresponding to the c-myc site (supplemental Fig. 5, A and  B) and was supershifted by a Blimp-1-specific mAb (supplemental Fig. 5, A and B) . By contrast, mutated oligonucleotides or control isotype Ab did not affect the mobility of the shifted complex (supplemental Fig. 5, A and B) . Furthermore, ectopic Blimp-1 expression was sufficient to suppress the expression of endogenous IL-6 and MCP-1 in JAWS II cells, a murine immature DC line (33) (Fig. 6E) . Finally, we used a construct consisting of a minimal basal promoter fused with an intron 1 fragment of Il-6 containing the Blimp-1 binding site and the luciferase gene, and a similar construct containing the Ccl2 promoter fragment. We observed dose-dependent Blimp-1 suppression of luciferase expression with both constructs (Fig. 6F) . Taken together, these data indicate that Il-6 and Ccl2 are direct targets for Blimp-1 and that Blimp-1 negatively regulates these genes in DCs.
Discussion
A role for Blimp-1 in B cell and T cell lineages has been reported (18 -20) . In this study, we found increased DC populations in mice lacking Blimp-1. Specifically, the number of CD8
Ϫ cDCs was affected in CKO mice. Higher Blimp-1 expression is found in CD8 Ϫ cDC subpopulations. Our results suggest that Blimp-1 may function in CD8
Ϫ cDC homeostasis by providing a balance that prevents excessive expansion of CD8 Ϫ cDCs by certain positive regulators. Blimp-1 also regulates DC maturation, and therefore we have identified a novel role for Blimp-1 in the DC lineage that is functionally relevant to innate immunity.
Similar to mice lacking Prdm1 specifically in the B or T cell lineage (18 -20) , in vitro plasma cell differentiation is defective and T cell homeostasis is dysregulated in CKO mice. One striking phenotype found in T cell-specific deletion of Prdm1 in mice is severe colitis and body weight loss (19) . Autoimmune disease symptoms were not observed in CKO mice up to 5 mo of age (data not shown), although these mice displayed increased steady-state effector T cell populations. These discrepancies may have resulted from the use of a different lineage-specific Cre in the different systems. In particular, DC function was altered in our animals, which may have impaired the initiation of the inflammatory response. In contrast, we think that the altered levels of CD8 Ϫ cDCs in this study are probably not attributable to an indirect effect resulting from changes in cytokine levels from T and B cell lineages, for the following reasons. First, Ctrl and CKO mice do not differ significantly with respect to steady-state serum cytokine/chemokine levels as determined by multiplex bead array assays (supplemental Fig. 6 ). Second, cDC homeostasis is unaffected by deletion of Prdm1 in the mouse B cell lineage (data not shown). 3) T cellspecific Blimp-1 transgenic mice have normal distribution and numbers of splenic CD11c high cDCs when compared with control littermates (Y.-H. Chan and K.-I Lin, unpublished observation). In addition, the mice used in our study also harbored a Prdm1 deletion in endothelial cells, but Blimp-1 expression in endothelial cells is not functionally relevant during embryonic development (40) . The numbers and frequencies of T cells, B cells, and precDCs were normal or minimally affected in CKO spleen or peripheral lymphoid organs, suggesting that Blimp-1 deficiency in blood vessel endothelial cells does not interfere with the trafficking of newly generated hematopoietic cells into peripheral lymphoid tissues.
In this study, we demonstrated the expression of Blimp-1 transcripts in steady state murine splenic cDCs and BMDCs cultured with GM-CSF, and that Blimp-1 is induced following stimulusinduced maturation of BMDCs. What are the signals/molecules involved in regulating Blimp-1 expression in DC lineages during either steady state or maturation? We determined that various TLR ligands induce Blimp-1 expression in BMDCs, consistent with previous findings that conjugation of TLR4, TLR2, or TLR9 results in Blimp-1 activation in the B cell lineage (22) (23) (24) . Blimp-1 induction through TLR signaling is dependent on p38 MAPK and NF-B signaling pathways. Essential roles for these two pathways in DC maturation have been described in vitro (41, 42) . These findings are concordant with our finding that Blimp-1 is critical for BMDC maturation because it acts downstream of p38 MAPK and NF-B. Blimp-1 transcripts in B cells are also regulated by AP-1 and STAT3 (43, 44) . A JNK inhibitor did not influence Blimp-1 expression during BMDC maturation (data not shown), thus it is unlikely that AP-1 is involved in regulation of Blimp-1 expression in the DC lineage. The role of STAT3 in Blimp-1 induction during BMDC maturation remains to be determined. Whether p38 MAPK and NF-B pathways regulate steady state Blimp-1 expression in splenic CD8
Ϫ cDCs also awaits further investigation. Because CD8 Ϫ cDCs are found largely in the marginal zone of spleen or the subsinusal layer of peripheral lymph nodes (45, 46) , the microenvironment of these areas may provide signals for steady state Blimp-1 expression.
Blimp-1 negatively regulates homeostatic development of cDC subsets in vivo, and it also positively regulates DC maturation. CKO GM-CSF-supplemented BMDCs are less able to up-regulate MHCII in response to stimulation, which may explain why stimulation of BMDCs from CKO mice did not induce efficient allogeneic T cell proliferation. Accordantly, the induction of CD25, CD40, CD86, and MHCII surface markers was reduced in Flt3L-cultured CKO CD11c ϩ CD11b ϩ BMDCs following either poly I:C or CpG stimulation (supplemental Fig. 7) , suggesting that Blimp-1 may regulate genes generally important for response to DC maturation. Further identification of Blimp-1 targets in DC lineages may improve our understanding of the underlying causes of defective CKO BMDC maturation. Blimp-1-mediated suppression of Il-6 in the DC lineage may provide a clue. Il-6 knockout mice have a greater number of mature DCs in vivo and pretreatment with IL-6 suppresses BMDC maturation (47) , suggesting that defective DC maturation in CKO mice or cultures may result from enhanced IL-6 production, at least in part.
In conclusion, we have established two new roles for the transcriptional repressor Blimp-1 in the immune system: (1) maintenance of CD8 Ϫ cDC homeostasis and (2) promotion of DC maturation or function. Our studies provide insights into the mechanisms governing maintenance of homeostatic cDC development and also provide a molecular basis for designing agents to modulate immune tolerance or immunogenic responses.
